Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2026)
Raphael Pharmaceutical's (RAPH) quarterly Current Assets came in at $6000.0 in Q2 2026, down 78.57% year-over-year from $28000.0 in Q2 2025, and down 88.24% quarter-over-quarter from $51000.0 in Q4 2025.
Powered by 
Analysis
Raphael Pharmaceutical (RAPH) Current Assets (2020 - 2026) Analysis & Trends
Raphael Pharmaceutical has disclosed Current Assets across 7 years of filings, most recently posting $6000.0 for Q2 2026.
- In Q2 2026, Current Assets fell 78.57% year-over-year to $6000.0; the TTM figure through Jun 2026 stood at $6000.0 (down 78.57% YoY), while the FY2025 annual figure was $51000.0, up 104.0% from the prior year.
- Current Assets came in at $6000.0 for Q2 2026 at Raphael Pharmaceutical, down from $51000.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $402000.0 in Q3 2023 to a low of $5000.0 in Q3 2025.
- Average Current Assets over 5 years is $144882.4, with a median of $119000.0 recorded in 2022.
- Year-over-year, Current Assets jumped 237.82% in 2023 and sank 89.8% in 2025.
- Over 5 years, Current Assets stood at $331000.0 in 2022, then slipped by 28.4% to $237000.0 in 2023, then tumbled by 89.45% to $25000.0 in 2024, then jumped by 104.0% to $51000.0 in 2025, then slumped by 88.24% to $6000.0 in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $6000.0 in Q2 2026, $51000.0 in Q4 2025, and $5000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 34.96 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 13.95 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 12.54 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 18.45 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 8.07 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 5.82 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 4.62 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 7.31 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 4.74 Bn |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Dec 31, 2025 | 51,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 28,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 25,000.00 |
| Sep 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 126,000.00 |
| Mar 31, 2024 | 350,000.00 |
| Dec 31, 2023 | 237,000.00 |
| Sep 30, 2023 | 402,000.00 |
| Jun 30, 2023 | 118,000.00 |
| Mar 31, 2023 | 149,000.00 |
| Dec 31, 2022 | 331,000.00 |
| Sep 30, 2022 | 119,000.00 |
| Jun 30, 2022 | 196,000.00 |
| Mar 31, 2022 | 180,000.00 |
| Dec 31, 2021 | 422,000.00 |
| Sep 30, 2021 | 62,000.00 |
| Dec 31, 2020 | 323,000.00 |